We are live on ! Find out more
NFA

Nationwide Fund Advisors Portfolio holdings

AUM $2.42B
1-Year Est. Return 17.68%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+17.68%
3 Year Est. Return
+28.25%
5 Year Est. Return
+4.07%
10 Year Est. Return
+82.68%
AUM
$24.9B
AUM Growth
+$60.2M
Cap. Flow
-$621M
Cap. Flow %
-2.49%
Top 10 Hldgs %
10.73%
Holding
3,382
New
186
Increased
1,366
Reduced
1,153
Closed
175

Top Buys

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$36.8M
2
DXC icon
DXC Technology
DXC
+$35.4M
3
ORCL icon
Oracle
ORCL
+$34M
4
META icon
Meta Platforms (Facebook)
META
+$34M
5
C icon
Citigroup
C
+$27.6M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$48.9M
2
T icon
AT&T
T
+$36.8M
3
BAC icon
Bank of America
BAC
+$30.8M
4
BCR
CR Bard Inc.
BCR
+$28.5M
5
PNRA
Panera Bread Co
PNRA
+$26.1M

Sector Composition

Rank Sector Weight
1 Technology 17.36%
2 Financials 15.07%
3 Healthcare 13.54%
4 Industrials 12.74%
5 Consumer Discretionary 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCTL
3051
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$53K ﹤0.01%
+8,447
New +$57.9K
EVI icon
3052
EVI Industries
EVI
$195M
$51K ﹤0.01%
+1,878
New +$43.5K
MTNB icon
3053
Matinas BioPharma
MTNB
$1.91M
$50K ﹤0.01%
+597
New +$80.2K
LEAF
3054
DELISTED
Leaf Group Ltd.
LEAF
$50K ﹤0.01%
+6,417
New +$52K
PTGX icon
3055
Protagonist Therapeutics
PTGX
$8.55B
$49K ﹤0.01%
4,345
TCS
3056
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$49K ﹤0.01%
551
AST
3057
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$49K ﹤0.01%
13,931
GWRS icon
3058
Global Water Resources
GWRS
$215M
$48K ﹤0.01%
4,826
XBIT icon
3059
XBiotech
XBIT
$68.6M
$48K ﹤0.01%
10,143
USAP
3060
DELISTED
Universal Stainless & Alloy
USAP
$48K ﹤0.01%
2,462
FLNT
3061
Fluent
FLNT
$106M
$47K ﹤0.01%
1,550
GNK icon
3062
Genco Shipping & Trading
GNK
$1.1B
$47K ﹤0.01%
+5,000
New +$53.2K
VHI icon
3063
Valhi
VHI
$389M
$47K ﹤0.01%
1,326
PCO
3064
DELISTED
Pendrell Corporation - Class A
PCO
$46K ﹤0.01%
+63
New +$39.4K
MCHX icon
3065
Marchex
MCHX
$77.8M
$44K ﹤0.01%
14,894
-8,258
-36% -$23.3K
ECYT
3066
DELISTED
Endocyte, Inc. Common Stock
ECYT
$44K ﹤0.01%
29,221
+8,270
+39% +$17.8K
RVLT
3067
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$44K ﹤0.01%
+6,618
New +$51.5K
CVEO icon
3068
Civeo
CVEO
$356M
$43K ﹤0.01%
1,705
+600
+54% +$17.9K
ENLC
3069
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$42K ﹤0.01%
+2,414
New +$43.1K
NH
3070
DELISTED
NantHealth, Inc
NH
$42K ﹤0.01%
+669
New +$37.1K
AKTS
3071
DELISTED
Akoustis Technologies Inc
AKTS
$41K ﹤0.01%
+4,665
New +$46.2K
GCBC icon
3072
Greene County Bancorp
GCBC
$581M
$40K ﹤0.01%
2,952
ABCD
3073
DELISTED
Cambium Learning Group, Inc.
ABCD
$40K ﹤0.01%
7,885
HIND
3074
Vyome Holdings
HIND
$14M
0
PRCP
3075
DELISTED
Perceptron Inc
PRCP
$38K ﹤0.01%
+5,200
New +$41.1K

Similar funds

Nationwide Fund Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Nationwide Fund Advisors held 3,382 positions worth $24.9B, up 0.24% from $24.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Nationwide Fund Advisors's Q2 2017 filing shows 186 new, 1,366 increased, 1,153 reduced and 175 closed positions. Its largest new stake was DXC Technology: 533,915 shares worth $35.4M. The largest sale was Apple, an estimated $48.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Nationwide Fund Advisors's largest Q2 2017 buy was DXC Technology: 533,915 shares worth $35.4M.
  • Nationwide Fund Advisors added most to Monster Beverage in Q2 2017, an estimated $36.8M increase.
  • Nationwide Fund Advisors's biggest Q2 2017 reduction was Apple, cutting an estimated $48.9M.
  • Nationwide Fund Advisors fully exited Computer Sciences in Q2 2017, selling an estimated $24.5M.
  • Nationwide Fund Advisors's ten largest holdings make up 11% of its $24.9B portfolio in Q2 2017.
  • Nationwide Fund Advisors opened 186 new positions and closed 175 in Q2 2017.
  • Nationwide Fund Advisors's portfolio value rose 0.24% quarter-over-quarter to $24.9B.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.